CTNM - Contineum Therapeutics Inc. - Ordinary Shares - Class A
IEX Last Trade
19.42
0.510 2.626%
Share volume: 43,782
Last Updated: Fri 30 Aug 2024 09:56:41 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$18.91
0.51
2.70%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Total revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses | |
| Selling general and admin | |
| Research and development | |
| Total expenses | |
| Operating income | |
| Ebit | |
| Pretax income | |
| Income tax | |
| Net income basic | |
| Net income |